VA, VD3, VE, VK3, VB1, VB2, VB6, VB12, VC, Niacin, Calcium Pantothenate, Folic acid, Biotin, Organic trace elements, Amino acids, L-Carnitine, taurine, Electrolyte, Fructo-Oligo-Saccharides, Glucose.
MUTI VITAMIN, ELEMENTS AND AMINO ACIDS POWDER provides vitamins, amino acids, organic trace elements through drinking water, improving feed conversion and feed intake for poultry and animals.
MUTI VITAMIN, ELEMENTS AND AMINO ACIDS POWDER helps to provide stress protection for poultry and animals during growing, breeding, laying, gravidity, and recover after disease.
MUTI VITAMIN, ELEMENTS AND AMINO ACIDS POWDER helps the improvement of laying rate, fertilization rate, hatchability.
MUTI VITAMIN, ELEMENTS AND AMINO ACIDS POWDER helps the improvement of Feed Intake for poultry and animals.
MUTI VITAMIN, ELEMENTS AND AMINO ACIDS POWDER helps the improvement of feather growth of poultry, size, production & quality of eggs, commodization rate of broiler.
MUTI VITAMIN, ELEMENTS AND AMINO ACIDS POWDER helps to prevent of cannibalism, and improvement of Performance and Production of gallbladder after medication.
To be added with the rate of 1 kg/ 3000 liter of drinking water for 3 to ten days
100g, 200g,500g,1000g. or according to customer’s requirement
Keep away from the high temperature and sunshine, under cool, dry conditions
Alzheimer’s disease (AD), also known in medical literature as Alzheimer disease, is the most common form of dementia. There is no cure for the disease, which worsens as it progresses, and eventually leads to death. It was first described by German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after him. Most often, AD is diagnosed in people over 65 years of age, although the less-prevalent early-onset Alzheimer’s can occur much earlier. In 2006, there were 26.6 million people worldwide with AD. Alzheimer’s is predicted to affect 1 in 85 people globally by 2050.
Although Alzheimer’s disease develops differently for every individual, there are many common symptoms. Early symptoms are often mistakenly thought to be ‘age-related’ concerns, or manifestations of stress. In the early stages, the most common symptom is difficulty in remembering recent events, known as short term memory loss. When AD is suspected, the diagnosis is usually confirmed with tests that evaluate behaviour and thinking abilities, often followed by a brain scan if available, however, examination of brain tissue is required for a definitive diagnosis. As the disease advances, symptoms can include confusion, irritability, aggression, mood swings, trouble with language, and long-term memory loss. As the person’s condition declines they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Since the disease is different for each individual, predicting how it will affect the person is difficult. AD develops for an unknown and variable amount of time before becoming fully apparent, and it can progress undiagnosed for years. On average, the life expectancy following diagnosis is approximately seven years. Fewer than 3% of individuals live more than 14 years after diagnosis.
This video is targeted to blind users.
Article text available under CC-BY-SA
Creative Commons image source in video